⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Diclofenac gel 1%
ژل دیکلوفناک ۱٪
🦴 Musculo-Skeletal SystemTopical NSAID
🤰 Pregnancy:Dangerous / avoid🤱 Breastfeeding:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA022122ATC M02AA15
Market / country: 🇺🇸 USA
Voltaren Arthritis Pain (US)
🧮 Dose calculator
Osteoarthritis · Regimen source: FDA Voltaren gel · DirectionsFDA Voltaren gel · Uses
⛔ Each upper-body area (hand, wrist, elbow): 2 g; each lower-body area (foot, ankle, knee): 4 g; 4 times daily with the dosing card. Not more than 2 areas at once. Up to 21 days. Not effective for strains, sprains or bruises. FDA Voltaren gel · DirectionsFDA Voltaren gel · Uses
🛡️ Safety & information
Contraindications
- ⛔ Prior allergic reaction to any pain reliever or fever reducer; right before or after heart surgery. FDA Voltaren gel · Do not use
Warnings
- • Severe allergy (especially with aspirin allergy), liver damage with overuse, and stomach bleeding. FDA Voltaren gel · Warnings
Formulations
- Diclofenac sodium 1% gel (with dosing card) — gel 🇺🇸 USA FDA Voltaren gel · Package label
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Voltaren gel · Drug Facts – Warnings
“It is especially important not to use diclofenac at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Voltaren gel · Drug Facts – Warnings
“If pregnant or breast-feeding, ask a health professional before use.”
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA022122
- DailyMed (FDA label)FDA Voltaren gel
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDM02AA15
- Darooyab (Iran)Diclofenac-Topical
🇮🇷 Registered in Iran Darooyab · G-4569/Diclofenac-Topical
Dosage forms with Iranian generic codes, per Darooyab.
- 00426 · DICLOFENAC SODIUM 1% TOP GEL · ژل موضعی دیکلوفناک سدیم ۱ درصد
- 17102 · DICLOFENAC SODIUM 1.5% TOP SOLUTION · محلول دیکلوفناک سدیم ۱٫۵ درصد
- 22637 · DICLOFENAC PLASTER TOPICAL 120 mg · چسب دارویی دیکلوفناک ۱۲۰ میلیگرم
- 51908 · DICLOFENAC EPOLAMINE PATCH TOPICAL 1.3 % · پچ پوستی دیکلوفناک اپولامین ۱٫۳ درصد
- 52705 · DICLOFENAC SODIUM SOLUTION TOPICAL 2 % 60 mL · محلول موضعی دیکلوفناک سدیم ۲ درصد ۶۰ میلیلیتر
- 52867 · DICLOFENAC SODIUM GEL TOPICAL 1 % 60 g · ژل موضعی دیکلوفناک سدیم ۱ درصد ۶۰ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Voltaren gel · Package labelFDA Voltaren gel · DirectionsFDA Voltaren gel · UsesFDA Voltaren gel · Do not useFDA Voltaren gel · WarningsFDA Voltaren gel · Drug Facts – WarningsFDA Voltaren gel · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4569/Diclofenac-Topical
- Clinical review⚠ Unverified